Epidermolysis Bullosa Therapeutic Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com

Share Article

RnRMarketResearch.com adds “Epidermolysis Bullosa - Pipeline Review, H1 2015” to its store. The report provides an overview of the Epidermolysis Bullosa’s therapeutic pipeline.

Epidermolysis Bullosa Therapeutic Pipeline Review, H1 2015

Epidermolysis Bullosa Therapeutic Pipeline Review, H1 2015

Past News Releases

RSS

The report “Epidermolysis Bullosa - Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Epidermolysis Bullosa. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/epidermolysis-bullosa-pipeline-review-h1-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Epidermolysis Bullosa and special features on late-stage and discontinued projects. Companies discussed in this Epidermolysis Bullosa - Pipeline Review, H1 2015 report include Fibrocell Science, Inc., GlaxoSmithKline plc, InMed Pharmaceuticals Inc., RegeneRx Biopharmaceuticals, Inc., Scioderm, Inc., Shire Plc and TWi Pharmaceuticals, Inc.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are diacerein, Gene Therapy for Epidermolysis Bullosa, Gene Therapy to Activate Collagen Type VII for Recessive Dystrophic Epidermolysis Bullosa, GMHDFCOL-7, ICX-RHY, INM-750, RGN-137, SD-101 and SHP-608.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=393495 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Epidermolysis Bullosa, H1 2015 8
Number of Products under Development for Epidermolysis Bullosa - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Late Stage Development, H1 2015 12
Comparative Analysis by Clinical Stage Development, H1 2015 13
Comparative Analysis by Early Stage Development, H1 2015 14
Products under Development by Companies, H1 2015 15
Products under Investigation by Universities/Institutes, H1 2015 16
Epidermolysis Bullosa - Pipeline by Fibrocell Science, Inc., H1 2015 17
Epidermolysis Bullosa - Pipeline by GlaxoSmithKline plc, H1 2015 18
Epidermolysis Bullosa - Pipeline by InMed Pharmaceuticals Inc., H1 2015 19
Epidermolysis Bullosa - Pipeline by RegeneRx Biopharmaceuticals, Inc., H1 2015 20
Epidermolysis Bullosa - Pipeline by Scioderm, Inc., H1 2015 21
Epidermolysis Bullosa - Pipeline by Shire Plc, H1 2015 22
Epidermolysis Bullosa - Pipeline by TWi Pharmaceuticals, Inc., H1 2015 23
Assessment by Monotherapy Products, H1 2015 24
Number of Products by Stage and Target, H1 2015 26
Number of Products by Stage and Mechanism of Action, H1 2015 28
Number of Products by Stage and Route of Administration, H1 2015 30
Number of Products by Stage and Molecule Type, H1 2015 32
Epidermolysis Bullosa Therapeutics - Recent Pipeline Updates, H1 2015 44
Epidermolysis Bullosa - Dormant Projects, H1 2015 49
Epidermolysis Bullosa - Discontinued Products, H1 2015 50

List of Figures
Number of Products under Development for Epidermolysis Bullosa, H1 2015 8
Number of Products under Development for Epidermolysis Bullosa - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Comparative Analysis by Early Stage Products, H1 2015 14
Assessment by Monotherapy Products, H1 2015 24
Number of Products by Top 10 Targets, H1 2015 25
Number of Products by Stage and Top 10 Targets, H1 2015 26
Number of Products by Top 10 Mechanism of Actions, H1 2015 27
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Top 10 Routes of Administration, H1 2015 29
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 30
Number of Products by Top 10 Molecule Types, H1 2015 31
Number of Products by Stage and Top 10 Molecule Types, H1 2015 32

Explore more reports on Dermatology therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/dermatology-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@RnRMR
since: 06/2012
Follow >
RnR Market Research
Like >
Follow us on
Visit website